Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“ Valneva ” or the “ Company ”), a specialty vaccine company, today announces that it has filed a prospectus supplement as part of the renewal of its ...
VALNEVA Declaration of shares and voting rights ... 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: March 5, 2025 Number ...
SE announced earlier that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La ...
Valneva also has an ongoing license agreement with the Serum Institute of India (SII) to supply its vaccine at an affordable ...
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal ...
Valneva SE, a specialty vaccine company, announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion with its vaccine Ixchiq. In agreement ...
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq ... provide an update after each capital increase on a dedicated location on its corporate website in order to inform investors ...
Saint-Herblain (France), March 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 24, 2025, of its 2024 Universal Registration ...
Saint-Herblain (France), March 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (“Valneva” or the “Company”), a specialty vaccine company, today announces that it has filed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback